U.K. Analgesics Market, 2022-2030
The analgesics market in the UK is expected to reach a projected revenue of US$ 2,453.3 million by 2030. A compound annual growth rate of 5.1% is expected of the UK analgesics market from 2023 to 2030.
- Pharmaceuticals
- Pain Management
- analgesics market report
- Pain Management
Revenue, 2022 (US$M)
$1,644.1
Forecast, 2030 (US$M)
$2,453.3
CAGR, 2023 - 2030
5.1%
Report Coverage
UK
U.K. Analgesics Market, 2018-2030 (US$M)
Global Market
Related Markets
Ask Prism AI anything about the analgesics market report market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Every answer starts with GVR research, and every figure is cited.Explore Prism AI
UK analgesics market highlights
- The UK analgesics market generated a revenue of USD 1,644.1 million in 2022 and is expected to reach USD 2,453.3 million by 2030.
- The UK market is expected to grow at a CAGR of 5.1% from 2023 to 2030.
- In terms of segment, non-opioid was the largest revenue generating drug type in 2022.
- Compound Medication is the most lucrative drug type segment registering the fastest growth during the forecast period.
Analgesics market data book summary
| Market revenue in 2022 | USD 1,644.1 million |
| Market revenue in 2030 | USD 2,453.3 million |
| Growth rate | 5.1% (CAGR from 2022 to 2030) |
| Largest segment | Non-opioid |
| Fastest growing segment | Compound Medication |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Opioid, Non-opioid, Compound Medication |
| Key market players worldwide | Bayer AG, Assertio Holdings Inc, Johnson & Johnson, GSK PLC, AbbVie Inc, Novartis AG ADR, Viatris Inc, Teva Pharmaceutical Industries Ltd |
Other key industry trends
- In terms of revenue, UK accounted for 4.3% of the global analgesics market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany analgesics market is projected to lead the regional market in terms of revenue in 2030.
- Italy is the fastest growing regional market in Europe and is projected to reach USD 2,032.1 million by 2030.
No credit card required*
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Analgesics Market Report
Analgesics market report segmentation & scope
Analgesics Market Report Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Johnson & Johnson | View profile | 134,400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | www.jnj.com |
| Novartis AG ADR | View profile | 76,057 | Lichtstrasse 35, Basel, Switzerland, 4056 | www.novartis.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37,851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | www.tevapharm.com |
| AbbVie Inc | View profile | 50,000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | www.abbvieinvestor.com |
| GSK PLC | View profile | 70,200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | www.gsk.com |
| Bayer AG | View profile | 99,723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | www.bayer.com |
| Viatris Inc | View profile | 38,000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | www.viatris.com |
| Assertio Holdings Inc | View profile | 30 | 100 South Saunders Road, Suite 300, Lake Forest, IL, United States, 60045 | www.assertiotx.com |
U.K. analgesics market report
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Analgesics Market will help companies and investors design strategic landscapes.
Non-Opioid was the largest segment with a revenue share of 51.59% in 2022.
Horizon Databook has segmented the U.K. analgesics market based on opioid, non-opioid, compound medication covering the revenue growth of each sub-segment from 2018 to 2030.
- U.K. Analgesics Market Drug Type Outlook (Revenue, USD Million , 2018-2030)
- Opioid
- Non-opioid
- Compound Medication
- U.K. Analgesics Market Application Outlook (Revenue, USD Million , 2018-2030)
- Musculoskeletal
- Surgical and Trauma
- Cancer
- Neuropathic
- Migraine
- Obstetrical
- Fibromyalgia
- Pain due to Burns
- Dental/Facial
- Pediatric
- Other Drug Type
- U.K. Analgesics Market Route of Administration Outlook (Revenue, USD Million , 2018-2030)
- Oral
- Parenteral
- Transdermal
- Other Route of Administrations
- U.K. Analgesics Market Distribution Channel Outlook (Revenue, USD Million , 2018-2030)
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
Reasons to subscribe to analgesics market report databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of analgesics market report databook
- Our clientele includes a mix of analgesics market report companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. analgesics market report, including forecasts for subscribers. This country databook contains high-level insights into U.K. analgesics market report from 2018 to 2030, including revenue numbers, major trends, and company profiles.
U.K. Analgesics Market, 2018-2030 (US$M)
UK analgesics market report statistics, by drug type, 2018-2030 (US$M)
